Orchid Pharma Ltd (ORCHIDPHAR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Orchid Pharma Ltd (ORCHIDPHAR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile


  • Products Id :- GDPH63309D
  • |
  • Pages: 26
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Summary

Orchid Pharma Ltd (Orchid), formerly Orchid Chemicals & Pharmaceuticals Ltd is a pharmaceutical company that develops and manufactures pharmaceutical solutions such as formulations and API products. The company offers formulations such as cardiovascular products, neuropsychiatry products, anti-diabetic products, nutritional supplements and various other products. It provides API such as cephalosporins-orals, cephalosporins-injectibles, veterinary products and non-antibiotics, among others. Orchid offers veterinary products, which include cefalonium, cefquinome sulphate, ceftiofur hydrochloride and ceftiofur sodium, among others. The company provides services such as process and pharma research, new drug discovery, pre-clinical research, biotech research, intellectual property management and contract research, among others. It has presence in the UK, South Africa, India, the US and Ukraine, among others. Orchid is headquartered in Chennai, Tamil Nadu, India.

Orchid Pharma Ltd (ORCHIDPHAR)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Orchid Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Orchid Pharma Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Orchid Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Orchid Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Orchid Pharma Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Orchid Pharma Ltd, Pharmaceuticals & Healthcare, Deal Details 11

Private Equity 11

Nectar Lifesciences and Blackstone May Acquire Orchid Pharma 11

Partnerships 12

Orchid Chemicals & Pharma Enters Into Co-Development Agreement With Allecra Therapeutics 12

Licensing Agreements 13

Orchid Chemicals Plans To Enter Into Licensing Agreement With Pharma Companies 13

Asset Transactions 14

Hospira Healthcare Completes Acquisition of Manufacturing and R&D Facility from Orchid Chemicals & Pharma for USD218 Million 14

Acquisition 16

NCPC To Acquire Remaining 50% Stake In NCPC Orchid Pharma For USD 14 Million 16

Orchid Pharma Ltd-Key Competitors 17

Orchid Pharma Ltd-Key Employees 18

Orchid Pharma Ltd-Locations And Subsidiaries 19

Head Office 19

Other Locations & Subsidiaries 19

Recent Developments 21

Financial Announcements 21

May 26, 2017: Orchid Pharma registers turnover of Rs. 766 crore in FY17 21

Corporate Communications 22

Jan 05, 2018: Orchid Pharma Announces Resignation of Directors 22

Legal and Regulatory 23

Jan 08, 2018: Orchid Pharma: Establishment Inspection Report from US FDA 23

Sep 21, 2017: Orchid Pharma receives Establishment Inspection Report from US FDA 24

Apr 18, 2017: Orchid Pharma Provides Update on Sriperumbudur Manufacturing Facility 25

Appendix 26

Methodology 26

About GlobalData 26

Contact Us 26

Disclaimer 26

List of Figures

Orchid Pharma Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Orchid Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Orchid Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Orchid Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Orchid Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Orchid Pharma Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Orchid Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Orchid Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

List of Tables

Orchid Pharma Ltd, Pharmaceuticals & Healthcare, Key Facts, 2018 2

Orchid Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Orchid Pharma Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Orchid Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Orchid Pharma Ltd, Deals By Therapy Area, 2012 to YTD 2018 8

Orchid Pharma Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Nectar Lifesciences and Blackstone May Acquire Orchid Pharma 11

Orchid Chemicals & Pharma Enters Into Co-Development Agreement With Allecra Therapeutics 12

Orchid Chemicals Plans To Enter Into Licensing Agreement With Pharma Companies 13

Hospira Healthcare Completes Acquisition of Manufacturing and R&D Facility from Orchid Chemicals & Pharma for USD218 Million 14

NCPC To Acquire Remaining 50% Stake In NCPC Orchid Pharma For USD 14 Million 16

Orchid Pharma Ltd, Key Competitors 17

Orchid Pharma Ltd, Key Employees 18

Orchid Pharma Ltd, Other Locations 19

Orchid Pharma Ltd, Subsidiaries 19

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Orchid Pharma Ltd, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

select a license
Single User License
USD 250 INR 17845
Site License
USD 500 INR 35690
Corporate User License
USD 750 INR 53535

NEWSLETTER BY CATEGORY




Testimonials

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com